Natural Killer (NK) Cell Therapeutics Market Business Growth Analysis (CAGR of +17.4%) and Key Players are Kiadis Pharma, Phio Pharmaceuticals Corporation, Glycostem, EMERCell, Brink Biologics, Inc., Innate Pharma, Sanofi

Natural Killer (NK) Cell Therapeutics Market research report contains fundamental, secondary and advanced information related to the global status and trend, market size, sales volume, market share, growth, future trends analysis, segment and forecasts from 2020 - 2026. This report helps businesses to define their own strategies for the up gradation in the existing product, possible modifications required in the future product, sales, marketing promotion and distribution of the product in the existing and the new market. In this industry report, a thorough investment analysis is offered which forecasts imminent opportunities for the market players and develops the strategies to grow return on investment (ROI).

Global natural killer (NK) cell therapeutics market is rising gradually with a healthy CAGR of 17.4% in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. Growing awareness about NK cells in treatment of cancer and infectious diseases are major drivers for market growth.

Get Exclusive Sample (350 Pages PDF) of Natural Killer Cell Therapeutics Market Report: To Know the Impact of COVID-19 on this Industry @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-natural-killer-nk-cell-therapeutics-market

Major Competitors Included:

Kiadis Pharma,
Phio Pharmaceuticals Corporation,
Glycostem,
EMERCell,
Brink Biologics, Inc.,
Innate Pharma,
Sanofi,
Nkarta, Inc.,
Affimed GmbH,
CELGENE CORPORATION,
Fate Therapeutics,
Fortress Biotech,
NKT Therapeutics ,
NantKwest,
Sorrento Therapeutics, Inc.,
Bristol-Myers Squibb Company,
Takeda Pharmaceutical Company Limited,
Altor BioScience,
Regeneron Pharmaceuticals, Inc.,
Ziopharm Oncology, Inc.,
among others.

Natural Killer (NK) Cell Therapeutics Market Definition:

Natural killer cells (NK cells) are a type of lymphocyte (a white blood cell) responsible for killing virally infected cells and they are responsible for production of immune regulatory cytokines. These are components of the innate immune system. NK cells detect and controls the tumor cells in the body. NK cells therapeutics is applied in detection, treatment and management of various diseases such as cancer, gastrointestinal diseases and infectious diseases.

According to an article published in the National Center for Biotechnology Information, about 3-5% of human peripheral blood lymphocytes are NK cells. The emerging NK cell therapeutics is basically developed to target the cancer cells by controlling the various mechanisms of NK cells such as cytotoxicity.

Table of Contents: Natural Killer (NK) Cell Therapeutics Market

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Market Overview
5. Natural Killer (NK) Cell Therapeutics Market and Forecast by Types
6. Global Natural Killer (NK) Cell Therapeutics Market Analysis and Forecast by Applications
7. Global Natural Killer (NK) Cell Therapeutics Market Analysis and Forecast by Regions
8. North America Market Analysis and Forecast
9. South America Market Analysis and Forecast
10. Europe Market Analysis and Forecast
11. Asia Pacific Market Analysis and Forecast
12. Middle East & Africa Market Analysis and Forecast
13. Competition Landscape

Read the full Research Report along with a table of contents, facts and figures, charts, graphs, etc. @ https://www.databridgemarketresearch.com/toc/?dbmr=global-natural-killer-nk-cell-therapeutics-market

Segmentation: Natural Killer Cell Therapeutics Market

Natural Killer Cell Therapeutics Market: By Therapeutics

• NK Cell Therapies
• NK Cell Directed Antibodies
• Others

Natural Killer Cell Therapeutics Market: By Application

• Cancer
• Gastrointestinal Diseases
• Immunoproliferative Disorders
• Others

Natural Killer Cell Therapeutics Market: By End Users

• Hospitals
• Homecare
• Specialty Clinics
• Others

Natural Killer Cell Therapeutics Market: By Distribution Channels

• Hospital Pharmacy
• Online P harmacy
• Retail Pharmacy
• Others

Natural Killer Cell Therapeutics Market By Geography

• North America
• South America
• Europe
• Asia-Pacific
• Middle East & Africa

Key Developments in the Natural Killer (NK) Cell Therapeutics Market:

• In April 2019, Kiadis Pharma announced the acquisition of CytoSen Therapeutics, Inc. to acquire the natural killer (NK)-Cell platform established by CytoSen. This acquisition includes CytoSen’s CSTD002-NK, an NK-Cell therapy being developed for treatment of patients with acute myeloid leukemia. Kiadis will used the NK-Cell platform of CytoSen and develop a unique combination of NK-Cell and T-Cell platform

• In March 2019, Phio Therapeutics Corp. and Glycostem announced research collaboration for development of a combination of sd-rxRNA, Phio’s RNAi technology and oNKord, Glycostem’s NK-Cell generation thechnology for the treatment of cancer. This collaboration will develop an improved cellular immunotherapy by incorporation of sd-rxRNA in NK-Cells for cancer treatment

Competitive Analysis: Natural Killer (NK) Cell Therapeutics Market

Global natural killer (NK) cell therapeutics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of natural killer (NK) cell therapeutics market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Natural Killer Cell Therapeutics Market Drivers

• Increasing adoption of NK cells for cancer and infectious diseases treatment will increase the market size

• Growing research and development of NK cells to target tumor cells acts as driver for the market growth

• Increasing healthcare expenditure by government in development of immunotherapies is expected to fuel the growth of the market

• Rising prevalence of cancer incidence across the globe is escalating the market in the forecast period

Natural Killer Cell Therapeutics Market Restraints

• Lack of specific treatment by NK cells and poor in-vivo survival of the cells obstructs the market growth

• High cost associated with the therapies hampers the growth of the market in the forecast period

• Adverse side effects of the therapies will hinder the growth of the market

• Stringent regulatory policies for approval of immunotherapy challenges the market growth
Reasons to Purchase this Report

• Current and future of global natural killer (NK) cell therapeutics market outlook in the developed and emerging markets

• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

• Regions/Countries that are expected to witness the fastest growth rates during the forecast period

• The latest developments, market shares, and strategies that are employed by the major market players

Order a Copy of Global Natural Killer Cell Therapeutics Market Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-natural-killer-nk-cell-therapeutics-market

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

This release was published on openPR.